Scancell Holdings (SCLP) Price & Analysis

Q: What was Scancell Holdings PLC’s price range in the past 12 months?

Scancell Holdings PLC lowest share price was 7.26p and its highest was 18.00p in the past 12 months.

Q: What is Scancell Holdings PLC’s market cap?

Scancell Holdings PLC’s market cap is £101.18M.

Q: When is Scancell Holdings PLC’s upcoming earnings report date?

Scancell Holdings PLC’s upcoming earnings report date is Jan 29, 2026 which is in 112 days.

Q: How were Scancell Holdings PLC’s earnings last quarter?

Scancell Holdings PLC released its earnings results on Sep 11, 2025. The company reported 0.001p earnings per share for the quarter, beating the consensus estimate of N/A by 0.001p.

Q: Is Scancell Holdings PLC overvalued?

According to Wall Street analysts Scancell Holdings PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does Scancell Holdings PLC pay dividends?

Scancell Holdings PLC does not currently pay dividends.

Q: What is Scancell Holdings PLC’s EPS estimate?

Scancell Holdings PLC’s EPS estimate for its next earnings report is not yet available.

Q: How many shares outstanding does Scancell Holdings PLC have?

Scancell Holdings PLC has 1,037,781,400 shares outstanding.

Q: What happened to Scancell Holdings PLC’s price movement after its last earnings report?

Scancell Holdings PLC reported an EPS of 0.001p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.215%.

Q: Which hedge fund is a major shareholder of Scancell Holdings PLC?

Currently, no hedge funds are holding shares in GB:SCLP

Compare

19 Followers

SCLP Stock Chart & Stats

Day’s Range― - ―

52-Week Range7.26p - 18.00p

Previous CloseN/A

Volume797.06K

Average Volume (3M)1.22M

Market Cap

£101.18M

Enterprise Value110.83M

Total Cash (Recent Filing)£9.10M

Total Debt (Recent Filing)£15.56M

Price to Earnings (P/E)―

Beta-0.16

Next Earnings

Jan 29, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)<0.01

Shares Outstanding1,037,781,400

10 Day Avg. Volume584,660

30 Day Avg. Volume1,222,918

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Scancell Holdings News

Scancell Holdings Announces AGM and Annual Report Release

An update from Scancell Holdings ( ($GB:SCLP) ) is now available. Scancell Holdings plc has announced the release...

6d ago

Scancell Holdings: Strategic Share Acquisition by Vulpes Testudo Fund

An announcement from Scancell Holdings ( ($GB:SCLP) ) is now available. Scancell Holdings plc announced that Vulpes Testudo...

23d ago

Scancell Holdings’ Earnings Call: Strategic Growth Amid Financial Challenges

Scancell Holdings (($GB:SCLP)) has held its Q4 earnings call. Read on for the main highlights of the call....

27d ago

Scancell Holdings Reports Positive Trial Results and Strategic Developments

Scancell Holdings ( ($GB:SCLP) ) has provided an update. Scancell Holdings plc has reported positive results from its...

28d ago

Scancell Holdings to Announce Year-End Results and Business Update

An announcement from Scancell Holdings ( ($GB:SCLP) ) is now available. Scancell Holdings announced it will release its...

1M ago

Scancell Holdings Sees Increased Stake by Vulpes Testudo Fund

Scancell Holdings ( ($GB:SCLP) ) has provided an update. Scancell Holdings announced that Vulpes Testudo Fund, associated with...

2M ago

Scancell Holdings Sees Significant Share Acquisition by Vulpes Testudo Fund

Scancell Holdings ( ($GB:SCLP) ) has issued an announcement. Scancell Holdings plc announced that Vulpes Testudo Fund, associated...

2M ago

Scancell’s iSCIB1+ Shows Promising Results in Late-Stage Melanoma Trial

Scancell Holdings ( ($GB:SCLP) ) has shared an announcement. Scancell Holdings has announced promising results from its Phase...

3M ago

Scancell Holdings Announces Share Option Exercise and Increased Voting Shares

An announcement from Scancell Holdings ( ($GB:SCLP) ) is now available. Scancell Holdings plc announced the exercise of...

3M ago

Scancell Advances iSCIB1+ Immunotherapy in Phase 2 Melanoma Study

Scancell Holdings ( ($GB:SCLP) ) has provided an update. Scancell Holdings has initiated Cohort 4 of its Phase...

4M ago

SCLP FAQ

What was Scancell Holdings PLC’s price range in the past 12 months?

Scancell Holdings PLC lowest share price was 7.26p and its highest was 18.00p in the past 12 months.

What is Scancell Holdings PLC’s market cap?

Scancell Holdings PLC’s market cap is £101.18M.

When is Scancell Holdings PLC’s upcoming earnings report date?

Scancell Holdings PLC’s upcoming earnings report date is Jan 29, 2026 which is in 112 days.

How were Scancell Holdings PLC’s earnings last quarter?

Scancell Holdings PLC released its earnings results on Sep 11, 2025. The company reported 0.001p earnings per share for the quarter, beating the consensus estimate of N/A by 0.001p.

Is Scancell Holdings PLC overvalued?

According to Wall Street analysts Scancell Holdings PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Scancell Holdings PLC pay dividends?

Scancell Holdings PLC does not currently pay dividends.

What is Scancell Holdings PLC’s EPS estimate?

Scancell Holdings PLC’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Scancell Holdings PLC have?

Scancell Holdings PLC has 1,037,781,400 shares outstanding.

What happened to Scancell Holdings PLC’s price movement after its last earnings report?

Scancell Holdings PLC reported an EPS of 0.001p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.215%.

Which hedge fund is a major shareholder of Scancell Holdings PLC?

Currently, no hedge funds are holding shares in GB:SCLP

Scancell Holdings Stock Smart Score

Neutral

Fundamentals

Return on Equity

167.16%

Trailing 12-Months

Asset Growth

-2.06%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Scancell Holdings PLC

Scancell Holdings (SCLP) is a biotechnology company focused on the development of innovative immunotherapies for the treatment of cancer and infectious diseases. The company operates in the life sciences sector, leveraging its proprietary immunotherapy platforms, including Moditope and ImmunoBody, to create novel therapeutic products. Scancell's core products aim to stimulate the immune system to target and eradicate cancer cells more effectively, offering potentially groundbreaking treatments that address unmet medical needs.